Literature DB >> 22535723

Effect of sonographically guided cerebral glioma surgery on survival time.

Jia Wang1, Xi Liu, Yong Mei Ba, Yi Lin Yang, Guo Dong Gao, Liang Wang, Yun You Duan.   

Abstract

OBJECTIVES: We investigated the value of intraoperative sonography in improving the prevalence of total tumor resection and the survival time of patients who underwent resection of cerebral gliomas.
METHODS: One hundred thirty-seven patients who underwent sonographically guided surgery were followed for 6 to 60 months. In addition, 60 randomly selected patients (30 with low-grade gliomas and 30 with high-grade gliomas) who had surgery in our hospital without sonographic guidance served as the control group. Follow-up included the survival time, and the difference in the survival time between the study and control groups was statistically analyzed.
RESULTS: Total removal of the lesion was achieved in 77 cases (69%), and partial removal was achieved in 35 (31%). In the control low-grade glioma group, 6-month survival was 96.7%; 1-year survival was 73.3%; and 2-year survival was 53.3%. In the study low-grade glioma group, survival rates at 6 months, 1 year, and 2 years were 98.0%, 96.1%, and 88.2%, respectively. In the control and study high-grade glioma groups, survival rates at 6 months, 1 year, and 2 years were 83.3% and 93.4%, 43.3% and 59.2%, and 13.3% and 32.8%. When comparing survival at 6 months, 1 year, and 2 years between the control and study groups, there was no significant difference at 6 months (P > .05), but survival at 1 and 2 years was significantly different (P < .05).
CONCLUSIONS: Sonographically guided resection of cerebral gliomas helps the surgeon understand the relationship between the lesion and the surrounding structures. It is of value in improving the prevalence of total tumor resection and the patient's survival time.

Entities:  

Mesh:

Year:  2012        PMID: 22535723     DOI: 10.7863/jum.2012.31.5.757

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  5 in total

Review 1.  Treating malignant glioma in Chinese patients: update on temozolomide.

Authors:  Liang Chang; Jun Su; Xiuzhi Jia; Huan Ren
Journal:  Onco Targets Ther       Date:  2014-02-12       Impact factor: 4.147

Review 2.  New Hope in Brain Glioma Surgery: The Role of Intraoperative Ultrasound. A Review.

Authors:  Maria Angela Pino; Alessia Imperato; Irene Musca; Rosario Maugeri; Giuseppe Roberto Giammalva; Gabriele Costantino; Francesca Graziano; Francesco Meli; Natale Francaviglia; Domenico Gerardo Iacopino; Alessandro Villa
Journal:  Brain Sci       Date:  2018-11-19

Review 3.  State-of-the-art imaging for glioma surgery.

Authors:  Niels Verburg; Philip C de Witt Hamer
Journal:  Neurosurg Rev       Date:  2020-06-30       Impact factor: 3.042

4.  Intraoperative Ultrasound: Emerging Technology and Novel Applications in Brain Tumor Surgery.

Authors:  Giuseppe Roberto Giammalva; Gianluca Ferini; Sofia Musso; Giuseppe Salvaggio; Maria Angela Pino; Rosa Maria Gerardi; Lara Brunasso; Roberta Costanzo; Federica Paolini; Rina Di Bonaventura; Giuseppe Emmanuele Umana; Francesca Graziano; Paolo Palmisciano; Gianluca Scalia; Silvana Tumbiolo; Massimo Midiri; Domenico Gerardo Iacopino; Rosario Maugeri
Journal:  Front Oncol       Date:  2022-02-01       Impact factor: 6.244

Review 5.  Safe surgery for glioblastoma: Recent advances and modern challenges.

Authors:  Jasper Kees Wim Gerritsen; Marike Lianne Daphne Broekman; Steven De Vleeschouwer; Philippe Schucht; Brian Vala Nahed; Mitchel Stuart Berger; Arnaud Jean Pierre Edouard Vincent
Journal:  Neurooncol Pract       Date:  2022-03-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.